Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Frankel

Showing results (311-320 of 348) with videos related to

Pageof 35
Sort By:
Psychotherapy and Psychosomatics|January 1, 1978
Treatment of anxiety: a comparison of the usefulness of self-hypnosis and a meditational relaxation technique. An overviewH Benson, F H Frankel, R Apfel, et al.
Cancer|December 14, 2022
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancerSayeh M Lavasani, George Somlo, Susan E Yost, et al.
Cancer Letters|December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cellsYujun Wang, Ernest Han, Quanhua Xing, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
The Journal of Trauma|March 1, 1996
Subcutaneous tissue oxygen pressure: a reliable index of peripheral perfusion in humans after injuryW Drucker, F Pearce, L Glass-Heidenreich, et al.
BMC Nephrology|January 4, 2022
Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021D Banerjee, P Winocour, T A Chowdhury, et al.
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2022
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney diseaseJanaka Karalliedde, Peter Winocour, Tahseen A Chowdhury, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Pageof 35

Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
Psychotherapy and Psychosomatics|January 1, 1978
Treatment of anxiety: a comparison of the usefulness of self-hypnosis and a meditational relaxation technique. An overviewH Benson, F H Frankel, R Apfel, et al.
Cancer|December 14, 2022
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancerSayeh M Lavasani, George Somlo, Susan E Yost, et al.
Cancer Letters|December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cellsYujun Wang, Ernest Han, Quanhua Xing, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
The Journal of Trauma|March 1, 1996
Subcutaneous tissue oxygen pressure: a reliable index of peripheral perfusion in humans after injuryW Drucker, F Pearce, L Glass-Heidenreich, et al.
BMC Nephrology|January 4, 2022
Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021D Banerjee, P Winocour, T A Chowdhury, et al.
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2022
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney diseaseJanaka Karalliedde, Peter Winocour, Tahseen A Chowdhury, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Pageof 35